Oral Glycoprotein IIb/IIIa Inhibitors

Authors:

Abstract
Despite their promise as orally active potent inhibitors of platelet aggregation, the oral platelet glycoprotein IIb/IIIa inhibitors have failed to provide a reduction in late ischemic events. In...

This publication has 32 references indexed in Scilit: